▼ 1.13%
prev close
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Congressional Trades
7
All tracked trades
Members Trading
2
Unique members
Net Activity
-3
2 buys · 5 sells
Members Who Traded This Stock
7 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-10-31 | ILMNIllumina, Inc. - Common Stock | Sell | $1,001 - $15,000 | 194d ago | — | |
| 2025-10-30 | ILMNIllumina, Inc. - Common Stock | Sell | $1,001 - $15,000 | 194d ago | — | |
| 2025-06-09 | ILMNIllumina, Inc. - Common Stock | Buy | $1,001 - $15,000 | 294d ago | — | |
| 2024-03-11 | ILMNIllumina, Inc. - Common Stock | Sell | $1,001 - $15,000 | 784d ago | — | |
| 2024-02-12 | ILMNIllumina, Inc. - Common Stock | Buy | $15,001 - $50,000 | 818d ago | — | |
| 2024-02-09 | ILMNIllumina, Inc. - Common Stock | Sell | $1,001 - $15,000 | 818d ago | — | |
| 2024-01-02 | ILMNIllumina, Inc. - Common Stock | Sell | $1,001 - $15,000 | 863d ago | — |
2025-10-31
Lisa McClain
ILMN
Amount
$1,001 - $15,000
Filed
194d ago
2025-10-30
Lisa McClain
ILMN
Amount
$1,001 - $15,000
Filed
194d ago
2025-06-09
Lisa McClain
ILMN
Amount
$1,001 - $15,000
Filed
294d ago
2024-03-11
Michael C. Burgess
ILMN
Amount
$1,001 - $15,000
Filed
784d ago
2024-02-12
Michael C. Burgess
ILMN
Amount
$15,001 - $50,000
Filed
818d ago
2024-02-09
Michael C. Burgess
ILMN
Amount
$1,001 - $15,000
Filed
818d ago
2024-01-02
Michael C. Burgess
ILMN
Amount
$1,001 - $15,000
Filed
863d ago
Recent News
Powered by Polygon.io
Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight
Cancer Biomarkers Market Outlook 2026–2031: Growing at a 8.65% CAGR, Driven by Precision Oncology and Early Detection Demand, Says Mordor Intelligence
Global AI in Life Sciences Market Gearing Up for Outstanding Expansion at a CAGR of ~20% by 2034 | DelveInsight
Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight
Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight
Trade Timeline
Congressional activity, newest first
Lisa McClain
2025-10-31 · Sale
$1,001 - $15,000
Lisa McClain
2025-10-30 · Sale
$1,001 - $15,000
Lisa McClain
2025-06-09 · Purchase
$1,001 - $15,000
Michael C. Burgess
2024-03-11 · Sale
$1,001 - $15,000
Michael C. Burgess
2024-02-12 · Purchase
$15,001 - $50,000
Michael C. Burgess
2024-02-09 · Sale
$1,001 - $15,000
Michael C. Burgess
2024-01-02 · Sale
$1,001 - $15,000